So why would they be using oral
Given the neuroprotective effects of both GLP-1 and estradiol, it would also be interesting to know how such agents might reduce neurodegeneration, especially in menopausal women
GLP-1RAs have effects on limiting atherosclerosis, controlling hypertension, and delaying the progression of heart failure, myocardial infarction, and cardiomyopathy
Together, the effects of stimulating insulin, reducing glucagon, and delaying gastric emptying improve glycemic control, resulting in a favorable hypoglycemia profile
Why you cannot simply convert doses between peptides A question that comes up constantly: "I am on 10mg of tirzepatide, what is the equivalent retatrutide dose?" The honest answer is that there is no direct equivalence
This differs from many telehealth providers that require a minimum BMI of 27-30 before prescribing GLP-1 medications